[Neurobiological deficit in individuals over 50 years of age. From physiopathology to therapy].
Sevestre
M
M
Djian
J
J
D000368:Aged; D000375:Aging / Q000502:physiology*; D001928:Brain Diseases, Metabolic / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000517:prevention & control; D018492:Dopamine Antagonists; D004341:Drug Evaluation; D004569:Electroencephalography; D006801:Humans; D008875:Middle Aged; D011724:Pyridazines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009435:Synaptic Transmission / Q000187:drug effects
D000697:Central Nervous System Stimulants; D018492:Dopamine Antagonists; D011724:Pyridazines; C006149:minaprine
Le déficit neurobiologique de la post-cinquantaine. De la physiopathologie à la thérapeutique.